Document is current
Any future updates will be listed below
-
Authors
Hall, Rasheeda K. https://orcid.org/0000-0002-3057-4828
Cary, Michael P. Jr. https://orcid.org/0000-0002-7966-7515
Washington, Tiffany R.
Colón-Emeric, Cathleen S. https://orcid.org/0000-0001-7681-8624
-
Funding
Funding for this research was provided by:
National Institute on Aging (P30AG028716)
National Institute on Aging (R03AG050834)
National Institute on Aging (K76AG059930)
National Institute on Aging (K24AG049077-01A1)
National Institute on Aging (P30 AG028716)
National Institute on Aging (P30 AG028716)
National Center for Advancing Translational Sciences (KL2TR002554)
National Center for Advancing Translational Sciences (UL1TR002378)
Doris Duke Charitable Foundation (2015207)
- License Information
-
More Information
Article History
Accepted: 23 October 2019
First Online: 5 November 2019
Compliance with ethical standards
:
: CCE acknowledges the following disclosures: acting as a consultant for Novartis and Amgen (DSMB Chair, CEC Chair); use of patents for bisphosphonate medications in cardiovascular indications; Co-owner Biscaria Inc.—studying non-bone uses of bisphosphonate medications. MPC acknowledges the following disclosures: receipt of royalties from an UpToDate online article that he co-authored. RKH and TRW have no conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (Duke University Institutional Review Board Protocol ID Pro00063355) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
